Last Price (USD) | 70.100 |
Prev. Close | 70.100 |
Day Range | 0.000 - 0.000 |
52WK range | |
Turnover (M USD) | 0.000 |
Volume (M) | 0.000 |
Number of Trades | 0 |
Market Cap (M USD) | 10,964.873 |
Change in Market Cap (M USD) | |
VWAP (USD) | 0.000 |
EPS (TTM) | -- |
EX-Dividend Date | |
Dividend | |
Dividend Yield (%) | |
Beta | |
30D Avg Volume | -- |
30D Avg Turnover(M USD) | |
Outstanding Shares | |
Free Float Shares | -- |
Free Float % | -- |
Highest Market Cap | |
Date of Highest Mkt. Cap | |
Lowest Market Cap | |
Date of Lowest Mkt. Cap |
Cairo – Mubasher: The board of directors of Glaxo SmithKline (GSK Egypt) agreed to allow Hikma Pharmaceuticals Plc to conduct due diligence on the...
Cairo – Mubasher: Galxo Group Limited signed a non-binding term sheet with Hikma Pharmaceuticals Plc for the potential sale of its entire stake of...
UAE - Mubasher: Hikma Pharmaceuticals, listed on Nasdaq Dubai and the London Stock Exchange, issued five-year Eurobonds worth $500 million with an...
Cairo - Mubasher: Hikma Pharmaceuticals, a global company with local presence in the US, the MENA region, and Europe, has penned a licensing and distribution...
By: Ahmed AllamCairo – Mubasher: Hikma Pharmaceuticals’ investments in the Egyptian market range between $250 million and $300 million, the...